Cabot Stock of the Week 235
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
biotech
Read More
biotech Archives
Cabot Prime Pro Week Week Ending February 22, 2019
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Prime Week Ending February 22, 2019
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Undervalued Stocks Advisor Weekly Update
U.S. stocks continue to defy gravity, with their audacious 2019 year-to-date gains mirroring their equally extreme fourth quarter 2018 descent.
Read More
Current Market Update
From Cabot Top Ten Trader
The overall action from the major indexes and leading stocks remains about as good as you could hope for considering we’re two months off a major bottom—we’re nudging up our Market Monitor another notch (to 8) in this issue to the...
Read More
Cabot Top Ten Trader Movers & Shakers Weekly Update
Big picture we remain very optimistic that the path of least resistance remains higher—the action of the market itself since the low, including the green light from the 2-to-1 Blastoff Indicator, looks like the initial thrust off a major low that should result higher...
Read More
Cabot Small-Cap Confidential Weekly Update
Small caps keep grinding higher. And many of the stocks in our portfolio are trading at, or near, all-time highs.
Read More
Cabot Growth Investor 1413
It’s Not the News that Counts
One of the biggest banana peels that many investors slip up on is the desire to focus on the news, be it economic reports, high-profile earnings releases or important political rumors (like the current U.S.-China trade talks). But it...
Read More
Cabot Stock of the Week 234
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
U.S. stocks delivered great performance in January and are now taking a breather. As such, I expect the S&P 500 index to trade between 2625 and 2825 for a while. The trading range might end up being a little higher or a little but...
Read More
Cabot Prime Pro Week Week Ending February 15, 2019
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Prime Week Ending February 15, 2019
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Daily Alert – 2/11/19
This biotech is somewhat speculative, but analysts expect it to grow by 22% annually for the next five years.
Read More
Cabot Top Ten Trader Movers & Shakers Weekly Update
After six very strong weeks on the upside, the sellers finally showed up in the middle of the week. Some retrenchment was likely, and so far, it’s been well within normal bounds. We remain mostly optimistic longer term, as enough bullish evidence has to...
Read More
Cabot Small-Cap Confidential Weekly Update
The market continues to look good as stocks are grinding higher with a few normal-looking down days mixed in (like yesterday) to keep investors honest. Average in, spread out your buys across different stocks, and take note of the current trading range and support,...
Read More
Cabot Growth Investor Bi-weekly Update
The sellers finally showed up today, with some negative headlines causing the market to pull back. In the Model Portfolio, we’re standing pat tonight with 35% in cash, though we’re spying a few names for possible new buying.
Read More
Cabot Emerging Markets Investor 678
We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More
Wall Street’s Best Dividend Stocks 317
Market Views
Bullish; Time for Strategic Buying
With the emerging markets outlook continuing to improve, investors shouldn’t worry about the lack of upside catalysts in the coming months. The U.S. stock market is still benefiting from strong corporate earnings momentum and equally strong internal momentum on...
Read More
Cabot Stock of the Week 233
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Undervalued Stocks Advisor 219
Buying Low is the Best Revenge
We’ve successfully struck upon some successful trades recently in the days leading up to various companies’ earnings releases, including Apple (AAPL) and Knight-Swift Transportation (KNX). If you’re looking for another similar opportunity, scroll down to review Marathon Petroleum in...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up